Detection of early seeding of Richter transformation in chronic lymphocytic leukemia

慢性淋巴细胞白血病中里氏转化早期播散的检测

阅读:2
作者:Ferran Nadeu # ,Romina Royo # ,Ramon Massoni-Badosa # ,Heribert Playa-Albinyana # ,Beatriz Garcia-Torre # ,Martí Duran-Ferrer ,Kevin J Dawson ,Marta Kulis ,Ander Diaz-Navarro ,Neus Villamor ,Juan L Melero ,Vicente Chapaprieta ,Ana Dueso-Barroso ,Julio Delgado ,Riccardo Moia ,Sara Ruiz-Gil ,Domenica Marchese ,Ariadna Giró ,Núria Verdaguer-Dot ,Mónica Romo ,Guillem Clot ,Maria Rozman ,Gerard Frigola ,Alfredo Rivas-Delgado ,Tycho Baumann ,Miguel Alcoceba ,Marcos González ,Fina Climent ,Pau Abrisqueta ,Josep Castellví ,Francesc Bosch ,Marta Aymerich ,Anna Enjuanes ,Sílvia Ruiz-Gaspà ,Armando López-Guillermo ,Pedro Jares ,Sílvia Beà ,Salvador Capella-Gutierrez ,Josep Ll Gelpí ,Núria López-Bigas ,David Torrents ,Peter J Campbell ,Ivo Gut ,Davide Rossi ,Gianluca Gaidano ,Xose S Puente ,Pablo M Garcia-Roves ,Dolors Colomer ,Holger Heyn ,Francesco Maura ,José I Martín-Subero ,Elías Campo

Abstract

Richter transformation (RT) is a paradigmatic evolution of chronic lymphocytic leukemia (CLL) into a very aggressive large B cell lymphoma conferring a dismal prognosis. The mechanisms driving RT remain largely unknown. We characterized the whole genome, epigenome and transcriptome, combined with single-cell DNA/RNA-sequencing analyses and functional experiments, of 19 cases of CLL developing RT. Studying 54 longitudinal samples covering up to 19 years of disease course, we uncovered minute subclones carrying genomic, immunogenetic and transcriptomic features of RT cells already at CLL diagnosis, which were dormant for up to 19 years before transformation. We also identified new driver alterations, discovered a new mutational signature (SBS-RT), recognized an oxidative phosphorylation (OXPHOS)high-B cell receptor (BCR)low-signaling transcriptional axis in RT and showed that OXPHOS inhibition reduces the proliferation of RT cells. These findings demonstrate the early seeding of subclones driving advanced stages of cancer evolution and uncover potential therapeutic targets for RT.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。